Physician profile
Ryan N Evans
NPI 1659357606
$2,818.19
in general payments reported to CMS, 2019-2025
45 companies · $260 in 2025
The $260 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $488 · 2021: $536 · 2022: $433 · 2023: $358 · 2024: $429 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $270.86 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $247.69 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $209.98 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Janssen Pharmaceuticals, INC | $145.39 | 2019-2025 | Spravato |
| Pfizer INC. | $133.58 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.57 | 2019-2022 | |
| Cranial Technologies, INC | $120.18 | 2019-2025 | Doc Band |
| Dynavax Technologies Corporation | $119.10 | 2020-2025 | Heplisav-B |
| Abbvie INC. | $100.96 | 2022-2024 | |
| Amarin Pharma, INC. | $95.55 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $87.85 | 2020-2024 | Jornay Pm |
| Tris Pharma INC | $85.89 | 2021 | |
| Organon LLC | $81.54 | 2021-2025 | Nexplanon |
| Genentech USA, INC. | $63.37 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.16 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.